Correlation of methicillin-resistant Staphylococcus aureus vancomycin minimal inhibitory concentration results by Etest and broth microdilution methods with population analysis profile: lack of Etest overestimation of the MIC

被引:10
作者
Khatib, R. [1 ]
Riederer, K. [1 ]
Shemes, S. [1 ]
Musta, A. C. [1 ]
Szpunar, S. [1 ]
机构
[1] St John Hosp & Med Ctr, Dept Internal Med, Grosse Pointe Woods, MI 48236 USA
关键词
SUSCEPTIBILITY; DAPTOMYCIN; HETERORESISTANCE; TRENDS;
D O I
10.1007/s10096-012-1811-7
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Methicillin-resistant Staphylococcus aureus (MRSA) vancomycin minimum inhibitory concentrations (V-MICs) are sometimes reported to be higher according to Etest versus broth microdilution (BMD). These observations are often interpreted as an Etest overestimation of the actual MIC. We measured V-MIC of 484 MRSA blood isolates using Etest, BMD, and a modified BMD (M-BMD) with incremental dilutions parallel to the Etest scale, correlated the results with population analysis profile-area under the curve (PAP-AUC). All MIC tests were done in parallel. The mean V-MIC was comparable (1.83 +/- 0.44 [Etest], 1.88 +/- 0.67 [BMD] and 1.75 +/- 0.57 mg/L [M-BMD]; p = 0.9 [ANOVA]). The V-MICs/PAP-AUC correlation coefficient was 0.555 (Etest), 0.513 (BMD), and 0.586 (M-BMD). Etest MICs were equal (44.2 %), one dilution higher (21.9 %), two dilutions higher (2.5 %), one dilution lower (29.8 %), and two dilutions lower (1.6 %) than BMD MICs and were equal (61.5 %), one dilution higher (28.3 %), two dilutions higher (0.4 %), one dilution lower (9.5 %), and two dilutions lower (0.2 %) than M-BMD MICs. The mean PAP-AUC for Etest vs M-BMD among isolates with similar Etest/M-BMD MIC values was 0.25 +/- 0.15 vs 0.35 +/- 0.13 (p = 0.8), 0.46 +/- 0.16 vs 0.50 +/- 0.17 (p = 0.8), 0.64 +/- 0.19 vs 0.67 +/- 0.21 (p = 0.9), and 0.90 +/- 0.31 vs 0.88 +/- 0.25 (p = 1.0) for isolates with V-MIC of a parts per thousand currency sign1, 1.5, 2, and a parts per thousand yen3 mg/L respectively. These results suggest that Etest might not overestimate V-MIC in comparison to M-BMD or BMD; Etest and M-BMD tests depict comparable PAP-AUC and have a higher correlation with PAP-AUC than the conventional BMD, probably because of the more detailed results. Etest may be more suitable than conventional BMD for MIC outcome assessment because of the more detailed MICs.
引用
收藏
页码:803 / 806
页数:4
相关论文
共 33 条
  • [21] In vitro activities of ceftobiprole, dalbavancin, daptomycin, linezolid, and tigecycline against methicillin-resistant Staphylococcus aureus blood isolates: stratified analysis by vancomycin MIC
    Chong, Yong Pil
    Park, Su-Jin
    Kim, Hee Sueng
    Kim, Eun Sil
    Kim, Mi-Na
    Kim, Sung-Han
    Lee, Sang-Oh
    Choi, Sang-Ho
    Jeong, Jin-Yong
    Woo, Jun Hee
    Kim, Yang Soo
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2012, 73 (03) : 264 - 266
  • [22] Association between high vancomycin minimum inhibitory concentration and clinical outcomes in patients with methicillin-resistant Staphylococcus aureus bacteraemia - A retrospective cohort study
    Talha, Khawaja M.
    Ishaq, Hassan
    Ramesh, Rommel
    Tariq, Wajeeha
    Arshad, Verda
    Baddour, Larry M.
    Sohail, M. Rizwan
    Palraj, Raj
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2021, 40 (07) : 1503 - 1510
  • [23] Early Use of Daptomycin Versus Vancomycin for Methicillin-Resistant Staphylococcus aureus Bacteremia With Vancomycin Minimum Inhibitory Concentration >1 mg/L: A Matched Cohort Study
    Murray, Kyle P.
    Zhao, Jing J.
    Davis, Susan L.
    Kullar, Ravina
    Kaye, Keith S.
    Lephart, Paul
    Rybak, Michael J.
    CLINICAL INFECTIOUS DISEASES, 2013, 56 (11) : 1562 - 1569
  • [24] Efficacy and Safety of Daptomycin versus Vancomycin for Bacteremia Caused by Methicillin-Resistant Staphylococcus aureus with Vancomycin Minimum Inhibitory Concentration > 1 μg/mL: A Systematic Review and Meta-Analysis
    Samura, Masaru
    Kitahiro, Yuki
    Tashiro, Sho
    Moriyama, Hiromu
    Hamamura, Yuna
    Takahata, Isamu
    Kawabe, Rina
    Enoki, Yuki
    Taguchi, Kazuaki
    Takesue, Yoshio
    Matsumoto, Kazuaki
    PHARMACEUTICS, 2022, 14 (04)
  • [25] An Association Between Bacterial Genotype Combined With a High-Vancomycin Minimum Inhibitory Concentration and Risk of Endocarditis in Methicillin-Resistant Staphylococcus aureus Bloodstream Infection
    Miller, Clare E.
    Batra, Rahul
    Cooper, Ben S.
    Patel, Amita K.
    Klein, John
    Otter, Jonathan A.
    Kypraios, Theodore
    French, Gary L.
    Tosas, Olga
    Edgeworth, Jonathan D.
    CLINICAL INFECTIOUS DISEASES, 2012, 54 (05) : 591 - 600
  • [26] Clinical and Laboratory Characteristics of Invasive Infections Due to Methicillin-Resistant Staphylococcus aureus Isolates Demonstrating a Vancomycin MIC of 2 Micrograms per Milliliter: Lack of Effect of Heteroresistant Vancomycin-Intermediate S. aureus Phenotype
    Satola, S. W.
    Lessa, F. C.
    Ray, S. M.
    Bulens, S. N.
    Lynfield, R.
    Schaffner, W.
    Dumyati, G.
    Nadle, J.
    Patel, J. B.
    JOURNAL OF CLINICAL MICROBIOLOGY, 2011, 49 (04) : 1583 - 1587
  • [27] Is Vancomycin MIC "Creep" Method Dependent? Analysis of Methicillin-Resistant Staphylococcus aureus Susceptibility Trends in Blood Isolates from North East Scotland from 2006 to 2010
    Edwards, B.
    Milne, K.
    Lawes, T.
    Cook, I.
    Robb, A.
    Gould, I. M.
    JOURNAL OF CLINICAL MICROBIOLOGY, 2012, 50 (02) : 318 - 325
  • [28] Cost-Effectiveness Analysis of Linezolid, Daptomycin, and Vancomycin in Methicillin-Resistant Staphylococcus aureus: Complicated Skin and Skin Structure Infection Using Bayesian Methods for Evidence Synthesis
    Bounthavong, Mark
    Zargarzadeh, Amir
    Hsu, Donald I.
    Vanness, David J.
    VALUE IN HEALTH, 2011, 14 (05) : 631 - 639
  • [29] Methicillin-resistant Staphylococcus aureus (MRSA) in hospitalized children: correlation of molecular analysis with clinical presentation and antibiotic susceptibility testing (ABST) results
    N. Abdel-Haq
    H. Al-Tatari
    P. Chearskul
    H. Salimnia
    B. I. Asmar
    M. R. Fairfax
    M. Amjad
    European Journal of Clinical Microbiology & Infectious Diseases, 2009, 28
  • [30] Impact of the First Twenty-Four-Hour Area Under the Concentration-Time Curve/Minimum Inhibitory Concentration of Vancomycin on Treatment Outcomes in Patients With Methicillin-Resistant Staphylococcus aureus Bacteremia
    Higashi, Mika
    Nakano, Takafumi
    Sato, Keisuke
    Eguchi, Yukiomi
    Moriwaki, Norihiro
    Kamada, Mitsuhiro
    Ikeuchi, Tadahiro
    Kaneshige, Susumu
    Uchiyama, Masanobu
    Hayashi, Toshinobu
    Togawa, Atsushi
    Matsuo, Koichi
    Kamimura, Hidetoshi
    JOURNAL OF CLINICAL MEDICINE RESEARCH-CANADA, 2024, 16 (7-8): : 325 - 334